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Targeted Next-Generation Sequencing of a 12.5 Mb
Homozygous Region Reveals ANO10 Mutations
in Patients with Autosomal-Recessive Cerebellar Ataxia
Sascha Vermeer,1,* Alexander Hoischen,1 Rowdy P.P. Meijer,1 Christian Gilissen,1 Kornelia Neveling,1
Nienke Wieskamp,1 Arjan de Brouwer,1 Michel Koenig,5,6 Mathieu Anheim,7,8,9,10 Mirna Assoum,5
Nathalie Drouot,5 Slobodanka Todorovic,11 Vedrana Milic-Rasic,11 Hanns Lochmu¨ller,12
Giovanni Stevanin,8,9,10,13 Cyril Goizet,14 Albert David,15 Alexandra Durr,7,8,9,10,13 Alexis Brice,7,8,9,10,13
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Michael Kwint,1 Peer Arts,1 Jenny van der Wijst,2 Joris Veltman,1 Erik-Jan Kamsteeg,1 Hans Scheffer,1,16
and Nine Knoers1,16,*
Autosomal-recessive cerebellar ataxias comprise a clinically and genetically heterogeneous group of neurodegenerative disorders. In
contrast to their dominant counterparts, unraveling the molecular background of these ataxias has proven to be more complicated
and the currently known mutations provide incomplete coverage for genotyping of patients. By combining SNP array-based linkage
analysis and targeted resequencing of relevant sequences in the linkage interval with the use of next-generation sequencing technology,
we identified amutation in a gene and have shown its association with autosomal-recessive cerebellar ataxia. In a Dutch consanguineous
family with three affected siblings a homozygous 12.5Mb region on chromosome 3 was targeted by array-based sequence capture. Prior-
itization of all detected sequence variants led to four candidate genes, one of which contained a variant with a high base pair conserva-
tion score (phyloP score: 5.26). This variant was a leucine-to-arginine substitution in the DUF 590 domain of a 16K transmembrane
protein, a putative calcium-activated chloride channel encoded by anoctamin 10 (ANO10). The analysis of ANO10 by Sanger sequencing
revealed three additional mutations: a homozygous mutation (c.1150_1151del [p.Leu384fs]) in a Serbian family and a compound-
heterozygous splice-site mutation (c.1476þ1G>T) and a frameshift mutation (c.1604del [p.Leu535X]) in a French family. This illustrates
the power of using initial homozygosity mappingwith next-generation sequencing technology to identify genes involved in autosomal-
recessive diseases. Moreover, identifying a putative calcium-dependent chloride channel involved in cerebellar ataxia adds another
pathway to the list of pathophysiological mechanisms that may cause cerebellar ataxia.Autosomal-recessive cerebellar ataxias are a heterogeneous
group of rare neurodegenerative disorders inwhich progres-
sive spinocerebellar ataxia, due to involvement of the cere-
bellum, brainstem, and/or spinocerebellar long tracts, is
the key feature. Clinically, patients are characterized by
gait and balance impairment, upper limb coordination
problems, and impairment of speech, swallowing, and eye
movements. The overall prevalence is estimated to be
around five to six per 100,000.1 Autosomal-recessive cere-
bellar ataxias are often associated with other neurological
(e.g., polyneuropathy, spasticity) or nonneurological (e.g.,
cardiomyopathy, cataract) symptoms and can thus lead to
complex phenotypes. Most autosomal-recessive ataxias
have an early onset age, formerly defined as < 20 years of
age,2 but some have been shown to begin much later. In
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ular background of the recessive cerebellar ataxias has
been only partly elucidated. Many patients with a recessive
ataxia are therefore still left without a molecular diagnosis.
Here, we describe the identification of a gene involved in
autosomal-recessive cerebellar ataxia, with downbeat
nystagmus and involvement of lower motor neurons as
additional clinical features. The gene was identified in
a Dutch remotely consanguineous family (Figure 1A).
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Figure 1. Identifcation of ANO10 Mutation in the Dutch Family
A with Autosomal-Recessive Cerebellar Ataxia
(A) Pedigree for the Dutch family A together with the segregation
of the mutation identified in this family. M1/M1 indicates homo-
zygous carriers of the p.Leu510Arg mutation, and M1/þ indicates
heterozygous carriers. The proband is indicated by an arrow.
Unfortunately, DNA was not available for individual A:V.3.
(B) Coverage histogram of ANO10. Upper part: Sequence-read
histograms uploaded to the UCSC Genome Browser display the
sequencing depth of all exons of ANO10. Tracks displayed: scale,
chromosomal position, read depth histogram per bp (between
0 and 60-fold coverage; higher than 60-fold coverage is not dis-
played), RefSeq gene track, highly conserved elements (Phast-
Cons Placental Mammal Conserved Elements, 28-way Multiz
Alignment). Lower part: Next-generation sequencing-read
coverage of ANO10 exons 8–10. Tracks displayed: scale, chromo-
somal position, individual 454 sequencing reads, RefSeq gene
track.
(C) Mutation visualization in the IGV browser. Individual reads
overlapping with the mutation are displayed. Seventeen of eigh-
teen reads show the homozygous mutation at genomic position
chr3:43571913 (the reads are mapped and displayed on the þ
strand).
(D) Verification by Sanger sequencing of missense mutation
c.1529T>G (p.Leu510Arg) in ANO10 (accession number
NM_018075.3).
(E) Sequence comparison of ANO10 in different species. The
amino acid that is mutated in the Dutch family is depicted, indi-
cated by an arrow. The amino acid is highly conserved
throughout different species, including the fruit fly.
814 The American Journal of Human Genetics 87, 813–819, Decembonset between 20 and 35 years. Neurological investigation
revealed a gaze-evoked downbeat nystagmus with hyper-
metric saccades, dysarthric speech, and brisk knee reflexes.
Mild atrophy of the upper part of the lower limbs with
fasciculations was observed in two of the three affected
siblings. These two also had evidence of lower motor
neuron involvement on electromyography (Table 1). In
all three affected siblings, brain imaging displayed marked
cerebellar atrophy with normal supratentorial structures
(Figure S1, available online).
Homozygosity mapping using a 10K SNP array identified
five homozygous regions on chromosomes 3, 6, 10, 12,
and 16. Only the region on chromosome 3 was confirmed
by further finemapping with short tandem repeat markers,
which showed a locus of approximately 10.5 Mb on chro-
mosome 3p21.32-p22.3 with a LOD score of 3.6 in this
Dutch family. This locus could be further confirmed and
fine mapped with the use of a 6.0 SNP array (Affymetrix)
interrogating over 900,000 SNPs. The multipoint LOD
score calculations and haplotype analysis were performed
with GeneHunter (version 2.1, release 5.05) in the easy-
LINKAGE software package and Haplopainter software.
Within the major locus more than 80 genes are located,
of which 15 candidate genes were sequenced by traditional
Sanger sequencing, selected on the basis of their known
function and cerebellar expression. No mutations could
be identified in these genes. Subsequently, we targeted
the entire 12.5 Mb region on chromosome 3, as well as
nine smaller homozygous regions on chromosomes 1, 2,
3, 4, and 14, for array-based sequence capture followed
by next-generation sequencing (Table S1a). The arrayer 10, 2010
Table 1. Clinical Features of Patients with Recessive Cerebellar Ataxia and Mutations in ANO10
Patient A:VII.1 A:VII.2 A:VII.3 B:II.3 B:II.4 B:II.5 C:II.1 C:II.3
Age 50 48 47 42 39 35 60 55
Sex M M F F F M F F
Age at onset
(yrs)
25 20 32 15 15 13 45 25
Age at
assessment
50 48 47 42 39 35 57 49
Mental
retardation
no no no yes (mild) yes (moderate) no no no
Ocular
pursuit
downbeat
nystagmus
downbeat
nystagmus
downbeat
nystagmus
horizontal
and
vertical
nystagmus
horizontal
and vertical
nystagmus
horizontal
nystagmus
saccadic pursuit,
nystagmus
multidirectional
nystagmus
Saccades hypermetric hypermetric,
slow (vertical)
hypermetric hypermetric,
mild
no hypermetric,
mild
no slow saccades
Cerebellar
dysarthria
moderate moderate mild moderate mild moderate moderate moderate
Gait ataxia moderate moderate mild moderate moderate moderate severe moderate
Appendicular
ataxia
moderate moderate mild mild mild mild moderate moderate
Tendon
reflexes: UL
increased increased increased increased increased increased
triceps
increased increased
Tendon
reflexes:
LL (knee)
increased increased increased increased increased increased increased increased
Tendon
reflexes:
LL (ankle)
increased normal increased increased normal normal increased increased
Plantar
responses
extensor normal normal normal normal normal normal normal/
Babinski
Other
features
cold and
blue toes
wasting and
fasciculations
proximal leg
muscles,
cold and blue
fingers
and toes
cold and
blue fingers
and toes
inspiratory
stridor
pes cavus fasciculations
leg muscles.
inspiratory
stridor and
vocal cord
paresis
mild lower
limb spasticity,
slight rest tremor,
pes cavus
episodic
diplopia,
pes cavus
EMG motor neuron
involvement
motor
neuron
involvement
not
done
not done not done motor neuron
involvement
not done normal
Cerebellar
atrophy seen
on MRI or CT
severe severe severe severe severe severe not done severe
Tortuosity of
conjunctival
vessels
absent absent absent present present present absent absentdesign included all known exons, untranslated regions
(UTRs), microRNAs, and highly conserved regions (Phast-
Cons Conserved Elements, 28-way MostCons Plac
Mammal Multiz Alignment, LOD score R 100) for all
homozygous regions.3,4 An additional 30 base pair (bp)
sequences flanking all exons were added to the regions
that were captured on the array so as to enable the detec-
tion of splice-site mutations. Targets smaller than 250 bp,
which is, based upon our experience, the minimum size
for the DNA capture protocol used, were enlarged by ex-The Americantending both ends of the region. The targeted sequences
comprise 1,905,376 bp in total (Table S1b), and include
1245 exons from 117 RefSeq genes and 187 UCSC genes,
as well as seven microRNAs and noncoding RNAs. After
stringent probe selection by NimbleGen (Roche Nimble-
Gen, Madison, WI, USA) (uniqueness tested by Sequence
Search and Alignment by Hashing Algorithm [SSAHA]),
a total of 2,178,492 bases (Table S1c) were represented on
an array, with 385,000 oligonucleotide probes targeting
the regions of interest. Sequence capture was performedJournal of Human Genetics 87, 813–819, December 10, 2010 815
Table 2. Overview of the Mutations Identified in ANO10
Family Proband
No. of Affected Siblings
with the Mutation
Mutation
(cDNA Level)
Mutation
(Protein Level)
Frequency in
Control Alleles
A VII.1 3 c.1529T>G/c.1529T>G p.Leu510Arg (homo) 0/300
B II.5 3 c.1150_1151del/ c.1150_1151del p.Leu384fs (homo) 0/300
C II.3 2 c.1476þ1G>T/c.1604del a/p.Leu535X (hetero) 0/300
a The effect of the splice-site mutation at the protein level has not been studiedin accordance with the manufacturer’s instructions (Roche
NimbleGen), with the use of the Titanium optimized
protocol. In brief, 5 mg of genomic DNA of the proband
(Figure 1A) was used in the preparation of the DNA library
for sequence-capture hybridization. A final amount of 3 mg
prehybridization ligation-mediated-PCR-amplified DNA
was hybridized to the customized array, eluted after 72 hr
of hybridization, and amplified by posthybridization
LM-PCR. The amplified captured sample was then used
as input for emulsion PCR amplification and subsequent
sequencing with the use of a Roche 454 GS FLX sequencer
with Titanium series reagents.
The sample was sequenced by using one-quarter plate of
a Roche sequencing run, yielding 83.7 Mb of sequence
data. Approximately 95.0% of the sequence data mapped
back to unique regions of the human genome (hg18,
NCBI build 36.1), with the use of the Roche Newbler soft-
ware (version 2.3). Of all mapped reads, 93.5% were
located on or near the targeted regions (i.e., within
500 bp proximity) (Table S2). This was sufficient to reach
an average of 32-fold coverage for all target regions. For
the region of interest, less than 1% of all targeted
sequences were not covered, and only 4.2% of the target
sequence was covered fewer than ten times (11% was
covered less than 15-fold).
The Roche software detected a total of 3917 high-con-
fidence variants, identifying the variant in at least three
reads. We used a custom-made data analysis pipeline as
described by Hoischen et al.5 to annotate detected variants
with various types of information, including known SNPs,
amino acid substitutions, genomic location, and evolu-
tionary conservation. A total of 3352 variants were found
to correspond to known SNPs, and 169 variants overlapped
with a known polymorphic region (dbSNP130) and were
therefore considered not likely to be disease-causing
variants. Of all remaining 396 variants, there were three
potential splice-site variants, two synonymous coding vari-
ants, and five nonsynonymous coding variants; of these
ten variants, only four were called as homozygous variants
(i.e., > 80% variant reads) (Tables S2 and S3). Of the four
remaining candidates, only two variants were conserved
during evolution,6 one of which had previously been re-
ported in our internal variant database in a patient with
a different disorder. The remaining single candidate was
a homozygous T>G change in ANO10 that was highly
conserved (phyloP score: 5.26) and also scored high on
the Grantham scale (145) (Table S3).816 The American Journal of Human Genetics 87, 813–819, DecembANO10 consists of 13 exons, 12 of which are coding,
spanning 2734 bp and 660 amino acids (NM_018075.3).
All exons of ANO10 were covered by sequence reads from
the targeted next-generation sequencing experiment
(Figure 1B). The homozygous T>G change at position
1529 that was detected by next-generation sequencing
occurred in exon 10 and is predicted to result in an amino
acid substitution of leucine by arginine at codon 510
(p.Leu510Arg). The mutated nucleotide (at position
g.43,571,913; hg18, NCBI build 36.1) was covered by
18 unique sequence reads. In 17 reads, the mutant
allele was detected, indicating that the mutation is present
in a homozygous state (Figure 1C). The c.1529T>G
(p.Leu510Arg) mutation was confirmed by conventional
Sanger sequencing and cosegregated with the disease in
this family (Figures 1A and 1D). The mutation was not
present in over 300 control alleles (Table 2). This residue
is conserved across multiple vertebrate species (Figure 1E)
and is located in the DUF590 domain, a domain of
unknown function.
Next, we analyzed this gene by conventional Sanger
sequencing in a consanguineous family (family B) with
three affected siblings of Romani ethnic origin from Serbia
(primer sequences are listed in Table S4). In family B an
independent linkage analysis was performed, and the
candidate region overlapped with the whole region in
the Dutch family initially studied (data not shown).
A homozygous 2 bp deletion (TT) at position 1150
(c.1150_1151del) was identified, leading to a frameshift
(p.Leu384fs) in exon 6 (Table 2). This frameshift mutation
cosegregated with the disease in this family (Figure 2) and
introduces a stop codon at position 474. The mutation
was not present in the dbSNP130 database and was not
detected in over 300 control alleles. The affected siblings
in this second cerebellar ataxia family also manifested
tortuosity of conjunctival vessels and intellectual disability
in two siblings (Table 1). Furthermore, ANO10 mutation
analysis was performed in a large cohort of 282 index
patients with cerebellar ataxia with presumable auto-
somal-recessive inheritance. In most patients of this
cohort, Friedreich ataxia (FA [MIM 22930]) had already
been excluded by mutation analysis of FRDA. Two com-
pound-heterozygous mutations, a splice-site mutation in
exon 9 (c.1476þ1G>T) and a nonsense mutation in
exon 10 (c.1604del [p.Leu535X]), were identified in a single
family (family C) with two affected siblings of French
descent (Figure 2). The phenotype of these patients iser 10, 2010
Figure 3. Expression of ANO10 in Different Human Tissues, Seen
by qPCR
(A) Expression of ANO10 in different adult tissues, with the high-
est expression seen in the brain.
(B) Expression of ANO10 in different brain tissues, with the high-
est expression seen in the adult cerebellum and frontal and
occipital cortices.
B:I.1 B:I.2 B:I.3
M2/+
B:I.4
B II.2:
+/+
B:II.3
M2/M2
B:II.4
M2/M2
B:II.5
M2/M2
Family B
B:II.6
M2/+
B:II.I
M2/+
C:I.2
M4/+
C:I.1
C:II.1 C:II.2 C:II.3
M3/M4M3/M4 M4/+
Family C
Figure 2. Pedigree Structure of TwoAdditional Families, B andC
Pedigrees for family B, from Serbia, and family C, from France,
together with the segregation of the mutations identified in these
families. M2/M2 indicates homozygous carriers of the p.Leu384fs
mutation, andM2/þ indicates heterozygous carriers, whereasþ/þ
indicates individuals with two wild-type alleles. M3/M4 indicates
compound-heterozygous carriers for the c.1476þ1G>T and the
p.Leu535X mutations, and M4/þ indicates heterozygous carriers
for the p.Leu535X mutation.
For family B, the degree of consanguinity is not known. Unfortu-
nately, DNA was not available for individual C:I.1.almost identical to the phenotype of the Dutch family
(Table 1). An overview of the mutations identified in
ANO10 is presented in Table 2. So far, we have identified
29 different SNPs in this gene.
In adult tissues, ANO10 has the highest expression in the
brain, as shown by quantitative PCR (qPCR) (Figure 3A).
Medium expression levels were found in the retina and
heart, and low expression levels were found in other tissues
tested. Comparing the ANO10 expression levels between
several adult brain areas showed the highest expression
levels in the frontal and occipital cortices and in the cere-
bellum(Figure3B). Inaddition,we found that the expression
of ANO10 in the fetal brain is lower than in the adult whole
brain, indicating a specific function for ANO10 in the adult
mature brain and especially in the cerebral cortex and the
cerebellum, rather than in brain development, although
a role of this gene inbrain development cannot be excluded.
The expression profile is consistent with the relatively late
onset of ataxia. However, ANO10, as well as ANO2 (MIM
610109) and ANO8 (MIM 610216), were detected with
similar distributions in the mantle layer of the neural tube
and in the dorsal root ganglia at embryonic day 14.5 in
murine embryos.7 Furthermore, expression studies during
cephalic development in the mouse seems to show embry-
onic expression of ANO10 during brain development.8The AmericanANO10, also known as TMEM16K (transmembrane
16K), is a member of the human anoctamin (ANO) family,
which comprises at least nine other proteins, all exhibiting
eight transmembrane domains and a DUF590 domain
of unknown function.9,10 Only very recently, it was
proposed that some or all of the anoctamin genes code
for cell- and tissue-specific calcium-activated chloride
channels.11–13 In murine tissues, ANO10 is predominantly
expressed in epithelial cells next to ANO1 (MIM 610108),
ANO6 (MIM 608663), ANO7 (MIM 605096), ANO8, and
ANO9, whereas ANO2, ANO3 (MIM 610110), ANO4 (MIM
610111), and ANO5 (MIM 608662) expression seem
common in neuronal and muscle tissues. On the basis of
results of the functional studies done by Schreiber et al.,
it appears likely that different anoctamins interact with
each other.11
It is known that calcium-activated chloride channels
have important physiological functions, including, among
others, regulation of neuronal excitability.14 Whether
ANO10 really codes for a calcium-regulated chloride
channel remains to be confirmed. In the phylogenic tree
of anoctamin genes, ANO1 is the member most distantJournal of Human Genetics 87, 813–819, December 10, 2010 817
from ANO10. A total of ~25 amino acids are missing from
the region coding for the reentrant loop between TM5 and
TM6 in ANO10, compared to ANO1,10 possibly blocking
the proper formation of a channel. It is also possible that
the ANO10 product can function only in combination
with other anoctamins to form heteromeric channels.
Notwithstanding this, it is tempting to speculate that
ANO10 indeed encodes a (subunit of a) calcium-regulated
chloride channel. Deranged calcium signaling in Purkinje
cells is one of the major mechanisms causing cerebellar
ataxia.15,16 Several products of known ataxia-associated
genes, such as calcium pumps and voltage-gated sodium
or potassium channels, may increase or dampen calcium-
signaling pathways in Purkinje cells.17–20 It could well be
that the ANO10 product, which is postulated to be
a calcium-dependent chloride channel, is also a player
influencing calcium signaling in Purkinje cells, and
a dysfunctional or absent ANO10 product may cause cere-
bellar ataxia via this mechanism. The identification of
a putative chloride channel involved in a relatively pure,
nonepisodic cerebellar ataxia may thus shed new light
on the pathological mechanisms leading to cerebellar
degeneration. Different molecular pathways, such as mito-
chondrial- and DNA-repair dysfunction, are already known
to be involved. As mentioned, in autosomal-dominant
cerebellar ataxias, involvement of calcium, sodium,
and potassium channels has been demonstrated.19,21,22
However, to our knowledge, the involvement of a
(calcium-activated) chloride channel in a cerebellar neuro-
degenerative disease has not yet been reported. Chloride
channels are known to be involved in other diseases,
such as myotonia congenita (MIM 160800 and MIM
255700), Dent disease (MIM 300009), cystic fibrosis
(MIM 219700), and Bartter syndrome (MIM 602522).23–26
At present, however, the basic function of ANO10 is
poorly understood, and so far most functional studies of
anoctamins have been performed with ANO1.
Dominant mutations in ANO5 (also known as GDD1)
have been associated with a rare skeletal disorder called
gnathodiaphyseal dysplasia (GDD [MIM 166260]).27
Recently, recessive mutations in ANO5 have been identi-
fied in patients with limb girdle muscular dystrophy type
2L (LGMD2L [MIM 611307]) and distal nondysferlin
Miyoshi myopathy (MMD3 [MIM 613319]).28 So far, no
other members of the anoctamin gene family have been
associated with genetic diseases in human.
In conclusion, we have identified mutations in ANO10
associated with autosomal-recessive cerebellar ataxia.
This report illustrates that the combination of homozy-
gosity mapping together with targeted array-based
sequencing is a powerful tool for identifying causative
genes for autosomal-recessive diseases. Mutations in
ANO10 have so far been identified in three different
families, with a total of eight patients, originating from
the Netherlands, Serbia, and France. The phenotype of
the patients is fairly similar (Table 1). Additional functional
studies are to be awaited in order to understand how818 The American Journal of Human Genetics 87, 813–819, Decembdysfunction of the ANO10-encoded putative chloride
channel results in cerebellar ataxia.Supplemental Data
Supplemental data include one figure and four tables and can be
found with this article online at http://www.cell.com/AJHG/.Acknowledgments
We are grateful to the patients for their participation, to the refer-
ring clinicians, and especially to C. Haaxma, E. Kamping,
E. Mundwiller, and the DNA and Cell Bank of the CR-ICM for their
clinical and technical support. This work was supported by a grant
from the Netherlands Organization of Health Research and
Development (ZonMW RM000085 to N.K.). The next-generation
sequencing platforms have been funded in part by the
Netherlands Organization for Health Research and Development
(ZonMW grants 917-66-36 and 911-08-025 to J.V.). Targeted
sequence-capture experiments were performed in part by funding
to H.S. from the European Community’s Seventh Framework Pro-
gramme FP7/2007-2013 under grant agreement number 223143
(project acronym: TECHGENE). Furthermore, we would like to
thank the Verum Foundation (support to A.B.), the French
National Agency for Research (support to A.D., M.K., and G.S.),
and AgenceNationale pour la Recherche-Maladies Neurologiques et
Psychiatriques (ANR-09-MNPS-001-01; support to M.K., A.D.,
and A.B.).
Received: August 9, 2010
Revised: October 6, 2010
Accepted: October 14, 2010
Published online: November 18, 2010Web Resources
The URLs for data presented herein are as follows:
dbSNP, build 130, http://www.ncbi.nlm.nih.gov/projects/SNP/
snp_summary.cgi?build_id¼130
easyLINKAGE, http://compbio.charite.de/genetik/hoffmann/
easyLINKAGE/
HaploPainter, http://haplopainter.sourceforge.net/
Integrative Genomics Viewer, http://www.broadinstitute.org/igv
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.
nlm.nih.gov/Omim/
RefSeq, http://www.ncbi.nlm.nih.gov/RefSeq/
University of California-Santa Cruz (UCSC) Genome Bioinfor-
matics, http://www.genome.ucsc.eduReferences
1. Anheim, M., Fleury, M., Monga, B., Laugel, V., Chaigne, D.,
Rodier, G., Ginglinger, E., Boulay, C., Courtois, S., Drouot, N.,
et al. (2010). Epidemiological, clinical, paraclinical and
molecular study of a cohort of 102 patients affected with
autosomal recessive progressive cerebellar ataxia from Alsace,
Eastern France: implications for clinical management. Neuro-
genetics 11, 1–12.
2. Harding, A.E. (1983). Classification of the hereditary ataxias
and paraplegias. Lancet 1, 1151–1155.er 10, 2010
3. Siepel, A., Bejerano, G., Pedersen, J.S., Hinrichs, A.S., Hou, M.,
Rosenbloom, K., Clawson, H., Spieth, J., Hillier, L.W.,
Richards, S., et al. (2005). Evolutionarily conserved elements
in vertebrate, insect, worm, and yeast genomes. Genome
Res. 15, 1034–1050.
4. Blanchette, M., Kent, W.J., Riemer, C., Elnitski, L., Smit, A.F.,
Roskin, K.M., Baertsch, R., Rosenbloom, K., Clawson, H.,
Green, E.D., et al. (2004). Aligning multiple genomic
sequences with the threaded blockset aligner. Genome Res.
14, 708–715.
5. Hoischen, A., van Bon, B.W., Gilissen, C., Arts, P., van Lier, B.,
Steehouwer, M., de Vries, P., de Reuver, R., Wieskamp, N.,
Mortier, G., et al. (2010). De novo mutations of SETBP1 cause
Schinzel-Giedion syndrome. Nat. Genet. 42, 483–485.
6. Pollard, K.S., Hubisz, M.J., Rosenbloom, K.R., and Siepel, A.
(2010). Detection of nonneutral substitution rates on
mammalian phylogenies. Genome Res. 20, 110–121.
7. Rock, J.R., Futtner, C.R., and Harfe, B.D. (2008). The trans-
membrane protein TMEM16A is required for normal develop-
ment of the murine trachea. Dev. Biol. 321, 141–149.
8. Gritli-Linde,A.,Vaziri Sani, F.,Rock, J.R.,Hallberg,K., Iribarne,D.,
Harfe, B.D., and Linde, A. (2009). Expression patterns of
the Tmem16 gene family during cephalic development in
the mouse. Gene Expr. Patterns 9, 178–191.
9. Galindo, B.E., and Vacquier, V.D. (2005). Phylogeny of the
TMEM16 protein family: some members are overexpressed
in cancer. Int. J. Mol. Med. 16, 919–924.
10. Hartzell, H.C., Yu, K., Xiao, Q., Chien, L.T., and Qu, Z. (2009).
Anoctamin/TMEM16 family members are Ca2þ-activated
Cl- channels. J. Physiol. 587, 2127–2139.
11. Schreiber, R., Uliyakina, I., Kongsuphol, P.,Warth, R., Mirza, M.,
Martins, J.R., and Kunzelmann, K. (2010). Expression and func-
tion of epithelial anoctamins. J. Biol. Chem. 285, 7838–7845.
12. Yang, Y.D., Cho, H., Koo, J.Y., Tak, M.H., Cho, Y., Shim, W.S.,
Park, S.P., Lee, J., Lee, B., Kim, B.M., et al. (2008). TMEM16A
confers receptor-activated calcium-dependent chloride
conductance. Nature 455, 1210–1215.
13. Caputo, A., Caci, E., Ferrera, L., Pedemonte, N., Barsanti, C.,
Sondo, E., Pfeffer, U., Ravazzolo, R., Zegarra-Moran, O., and
Galietta, L.J. (2008). TMEM16A, a membrane protein associ-
ated with calcium-dependent chloride channel activity.
Science 322, 590–594.
14. Hartzell, C., Putzier, I., and Arreola, J. (2005). Calcium-acti-
vated chloride channels. Annu. Rev. Physiol. 67, 719–758.
15. Carlson, K.M., Andresen, J.M., and Orr, H.T. (2009). Emerging
pathogenic pathways in the spinocerebellar ataxias. Curr.
Opin. Genet. Dev. 19, 247–253.
16. Kasumu, A., and Bezprozvanny, I. (2010). Deranged Calcium
Signaling in Purkinje Cells and Pathogenesis in Spinocerebel-
lar Ataxia 2 (SCA2) and Other Ataxias. The Cerebellum. Pub-
lished online May 18, 2010. 10.1007/s12311-010-0182-9.
17. Saegusa, H., Wakamori, M., Matsuda, Y., Wang, J., Mori, Y.,
Zong, S., and Tanabe, T. (2007). Properties of human Cav2.1
channel with a spinocerebellar ataxia type 6 mutation ex-
pressed in Purkinje cells. Mol. Cell. Neurosci. 34, 261–270.The American18. van de Leemput, J., Chandran, J., Knight, M.A., Holtzclaw,
L.A., Scholz, S., Cookson, M.R., Houlden, H., Gwinn-Hardy,
K., Fung, H.C., Lin, X., et al. (2007). Deletion at ITPR1 under-
lies ataxia in mice and spinocerebellar ataxia 15 in humans.
PLoS Genet. 3, e108.
19. Waters, M.F., Minassian, N.A., Stevanin, G., Figueroa, K.P.,
Bannister, J.P., Nolte, D., Mock, A.F., Evidente, V.G., Fee, D.B.,
Mu¨ller, U., et al. (2006). Mutations in voltage-gated potassium
channel KCNC3 cause degenerative and developmental
central nervous system phenotypes. Nat. Genet. 38, 447–451.
20. Trudeau, M.M., Dalton, J.C., Day, J.W., Ranum, L.P., and
Meisler, M.H. (2006). Heterozygosity for a protein truncation
mutation of sodium channel SCN8A in a patient with
cerebellar atrophy, ataxia, and mental retardation. J. Med.
Genet. 43, 527–530.
21. Zhuchenko, O., Bailey, J., Bonnen, P., Ashizawa, T., Stockton,
D.W., Amos, C., Dobyns, W.B., Subramony, S.H., Zoghbi,
H.Y., and Lee, C.C. (1997). Autosomal dominant cerebellar
ataxia (SCA6) associated with small polyglutamine expan-
sions in the alpha 1A-voltage-dependent calcium channel.
Nat. Genet. 15, 62–69.
22. Brusse, E., de Koning, I., Maat-Kievit, A., Oostra, B.A., Heutink,
P., and van Swieten, J.C. (2006). Spinocerebellar ataxia associ-
ated with a mutation in the fibroblast growth factor 14 gene
(SCA27): A new phenotype. Mov. Disord. 21, 396–401.
23. Lloyd, S.E., Pearce, S.H., Fisher, S.E., Steinmeyer, K., Schwap-
pach, B., Scheinman, S.J., Harding, B., Bolino, A., Devoto,
M., Goodyer, P., et al. (1996). A common molecular basis for
three inherited kidney stone diseases. Nature 379, 445–449.
24. Koch, M.C., Steinmeyer, K., Lorenz, C., Ricker, K., Wolf, F.,
Otto, M., Zoll, B., Lehmann-Horn, F., Grzeschik, K.H., and
Jentsch, T.J. (1992). The skeletal muscle chloride channel in
dominant and recessive human myotonia. Science 257,
797–800.
25. Riordan, J.R., Rommens, J.M., Kerem, B., Alon, N., Rozmahel,
R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.L.,
et al. (1989). Identification of the cystic fibrosis gene: cloning
and characterization of complementary DNA. Science 245,
1066–1073.
26. Birkenha¨ger, R., Otto, E., Schu¨rmann, M.J., Vollmer, M., Ruf,
E.M., Maier-Lutz, I., Beekmann, F., Fekete, A., Omran, H.,
Feldmann, D., et al. (2001). Mutation of BSND causes Bartter
syndrome with sensorineural deafness and kidney failure.
Nat. Genet. 29, 310–314.
27. Tsutsumi, S., Kamata, N., Vokes, T.J., Maruoka, Y., Nakakuki,
K., Enomoto, S., Omura, K., Amagasa, T., Nagayama, M.,
Saito-Ohara, F., et al. (2004). The novel gene encoding a puta-
tive transmembrane protein is mutated in gnathodiaphyseal
dysplasia (GDD). Am. J. Hum. Genet. 74, 1255–1261.
28. Bolduc, V., Marlow, G., Boycott, K.M., Saleki, K., Inoue, H.,
Kroon, J., Itakura, M., Robitaille, Y., Parent, L., Baas, F., et al.
(2010). Recessive mutations in the putative calcium-activated
chloride channel Anoctamin 5 cause proximal LGMD2L and
distal MMD3 muscular dystrophies. Am. J. Hum. Genet. 86,
213–221.Journal of Human Genetics 87, 813–819, December 10, 2010 819
